User Reviews for Lenvima
The following information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
| Condition | Avg. Rating | Reviews | Compare | |
|---|---|---|---|---|
| Renal Cell Carcinoma | 6.0 | 1 reviews | 16 medications | |
| Summary of Lenvima reviews | 6.0 | 1 reviews | ||
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
Reviews for Lenvima
More about Lenvima (lenvatinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
- Lenvima
- Lenvima (14 MG Daily Dose)
- Lenvima (18 MG Daily Dose)
- Lenvima (20 MG Daily Dose)
- Lenvima (24 MG Daily Dose)
- ... +2 more
For Renal Cell Carcinoma: “I used this and everolimus as my first line of treatment. Most of my side effects they contributed to everolimus. I had a partial response while on these drugs. I had elevated BP that was easily controlled by medication. I had protein urea that lasted the entire time. Once off these drugs my BP and protein returned to normal. Wish the effects had lasted longer”